Loading
Loading
Your feedback directly shapes Sporos.
Sign in to track your feedback history
Amends the Use Tax Act, the Service Use Tax Act, the Service Occupation Tax Act, and the Retailers' Occupation Tax Act. Provides that prescription medicines and products classified as Class III medical devices by the United States Food and Drug Administration that are used for cancer treatment pursuant to a prescription are exempt from the tax under the Acts. Amends the Illinois Income Tax Act. Increases the amount deposited into the Local Government Distributive Fund to: (i) 7.47% of the net revenue realized from the tax imposed upon individuals, trusts, estates, and pass-through entities; and (ii) 7.85% of the net revenue realized from the tax imposed upon corporations. Effective July 1, 2026.
Introduced
Feb 6, 2026
Last Action
Mar 13, 2026
Session
IL 104th
Sponsors
1 primary · 0 co
Rule 2-10 Committee Deadline Established As April 24, 2026
Chief Sponsor Changed to Sen. Darby A. Hills
Assigned to Revenue
Filed with Secretary by Sen. John F. Curran
Added as Chief Co-Sponsor Sen. Darby A. Hills
First Reading
Referred to Assignments
Get a plain-English explanation of what this bill does, who it affects, and why it matters.
Rule 2-10 Committee Deadline Established As April 24, 2026
Darby A. Hills